✦ LIBER ✦

Co-morbid diseases and their potential impact on the pharmacotherapy of heart failure

✍ Scribed by C. Blanton; G. O'Driscoll; R. Hendriks; M. Hobbs; P. Langton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of co-morbidities on the weal

✍ Schofield, Deborah J.; Callander, Emily J.; Shrestha, Rupendra N.; Passey, Megan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Utilization of Device Therapy in Heart F

✍ Spencer H. Kubo; Alan J. Bank; Thomas H. Johnson; Denise Carlson; Ann Hayden; Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

The Impact of Co-Morbid Peripheral Vascu

✍ Anna Kezerashvili; Jessica Delaney; Michael J. Schaefer; Gregory Janis; Ricardo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 141 KB

The Impact of Co-Morbid Chronic Obstruct

✍ Michael J. Schaefer; Anna Kezerashvili; Jessica Delaney; Gregory Janis; Ricardo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 105 KB

The Prevelence of Common Co-Morbidities

✍ Dmitry Abramov; Mathew S. Maurer; Daniel Burkhoff; Jie Wang; Kun-Lun He 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Chronic Kidney Disease is a Marker of In

✍ Lau, J.; Chang, M.; Ordys, B.; Jardine, M.; Al-kahwa, A.; Sindone, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB